featured
Trilaciclib Plus Topotecan for Patients With Extensive Stage Small Cell Lung Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: